Bariatric surgery is more cost effective than newer weight loss medications. Also, no possible complications of taking these drugs before bariatrics were found. This was shown in a study presented at the American College of Surgeons (ACS) Congress. Drugs that mimic the action of the hormone GPP-1 are effective in lowering blood sugar levels, suppressing appetite, and helping you lose weight. This group of drugs includes Ozempic, Vegovy, and other new drugs. In a new study, researchers found that the new weight loss drugs are less beneficial in the long run than bariatric surgery to reduce stomach volume. However, in the future, the cost of the drugs may come down and the results will change. In addition, the study was conducted in the United States, and the cost of surgeries and drugs may differ in other countries. Therefore, the results cannot be transferred to other countries. The second study presented at the meeting looked at data from people who took Ozempic or its analogs a year before surgery. It was not associated with health complications or worse bariatric outcomes.